Objective-The balance between apoptosis susceptibility and efferocytosis of macrophages is central to plaque remodeling and inflammation. LRP-1 and its ligand, apolipoprotein E, have been implicated in efferocytosis and apoptosis in some cell types. We investigated the involvement of the macrophage LRP-1/apolipoprotein E axis in controlling plaque apoptosis and efferocytosis. Method and Results-LRP-1 Ϫ/Ϫ macrophages displayed nearly 2-fold more TUNEL positivity compared to wild-type cells in the presence of DMEM alone or with either lipopolysaccharide or oxidized low-density lipoprotein. The survival kinase, phosphorylated Akt, was barely detectable in LRP-1 Ϫ/Ϫ cells, causing decreased phosphorylated Bad and increased cleaved caspase-3. Regardless of the apoptotic stimulation and degree of cell death, LRP-1 Ϫ/Ϫ macrophages displayed enhanced inflammation with increased IL-1␤, IL-6, and tumor necrosis factor-␣ expression. Efferocytosis of apoptotic macrophages was reduced by 60% in LRP-1 Ϫ/Ϫ vs wild-type macrophages despite increased apolipoprotein E expression by both LRP-1 Ϫ/Ϫ phagocytes and wild-type apoptotic cells. Compared to wild-type macrophage lesions, LRP-1 Ϫ/Ϫ lesions had 5.7-fold more necrotic core with more dead cells not associated with macrophages.
L RP-1 is a ubiquitous multifunctional receptor, and its systemic expression is essential for embryonic development. 1 LRP-1 is critical for the clearance of plasma remnants, because conditional hepatic LRP-1 deletion results in increased plasma triglyceride and chylomicron levels. 2 We have shown that deletion of macrophage LRP-1 increases atherosclerotic lesion formation in the proximal aorta of low-density lipoprotein receptor (LDLR) Ϫ/Ϫ mice without affecting serum lipoprotein levels and despite decreased macrophage uptake of apoE-containing very-low-density lipoprotein. 3 The enhanced atherosclerotic lesion formation was associated with increased formation of breaks in the elastic lamina, activated inflammation, and increased macrophage cellularity in the plaque. 3 Macrophages in atherosclerotic lesions undergo apoptosis and necrosis because of cholesterol toxicity, oxidative stress, and signaling from cytokines and other molecules. 4 -6 A determining factor in lesion formation, remodeling, and progression is the balance between the generation of apoptotic cells and their phagocytosis (efferocytosis), because noninternalized apoptotic cells secrete inflammatory cytokines, thus driving uncontrolled cell death and inducing plaque instability. 7 LRP-1 has been linked to the efferocytosis of apoptotic cells by macrophages and nonprofessional phagocytes through colocalization with ABCA7 and activation of extracellular signal-regulated kinases. 8, 9 However, it remains to be determined whether macrophage LRP-1 plays a significant role in efferocytosis of lesional apoptotic macrophages. Studies have shown that the Mertk receptor, not LRP-1, 4 mediates the efferocytosis of macrophages made apoptotic by free cholesterol burden, whereas other studies suggest that the Mertk receptor plays a significant role in efferocytosis of lesional apoptotic macrophages. 10 Besides mediating efferocytosis, it is possible that LRP-1 regulates macrophage susceptibility to apoptosis. Studies with cell types, including fibroblasts and neurons, have demonstrated that blockage of LRP-1/ligand interaction via receptor-associated protein enhances cell death under serum-free conditions. 11, 12 In addition, studies have shown that incubation of macrophages with antibodies directed against the ligand binding domain of LRP-1 results in increased diacylglycerol, cAMP, and intracellular calcium mobilization, 13, 14 raising the possibility that LRP-1 signaling regulates levels of phosphorylated Akt (pAkt), 15, 16 a critical player in promoting macrophage survival. 15, 17, 18 Macrophage apolipoprotein E (apoE) is a ligand for LRP-1 and a major determinant of atherosclerosis susceptibility 19 -21 by regulating cholesterol trafficking 22 and reducing oxidative stress. 23 Besides these atheroprotective functions, studies suggest that apoE may reduce inflammation by mediating efficient efferocytosis of apoptotic cells. 24 Compared to wild-type (WT) mice, apoE Ϫ/Ϫ mice show increased numbers of apoptotic cells and enhanced inflammatory responses in different tissues. 24 Furthermore, in vitro studies have demonstrated that the efferocytosis of apoE Ϫ/Ϫ apoptotic cells is impaired. 24 Consistent with the notion that apoE plays a role in efferocytosis, the synthesis of apoE is markedly enhanced in macrophages undergoing apoptosis, 25, 26 perhaps as a mechanism to increase recognition and internalization by neighboring phagocytes through LRP-1. In addition, studies have shown that apoE is linked to cell survival in other cell types, including ovarian 27 and neuronal cells. 28 In neurons, apoE signaling reduces susceptibility to apoptosis via interaction with a number of receptors, including apoE receptor 2, 29 LRP-4, 30 and LRP-1. 28 Our previous studies have demonstrated that deletion of macrophage LRP-1 increases atherosclerosis, plaque instability, inflammation, and macrophage cellularity. 3 Because apoE is a ligand for LRP-1, we postulated that a functional axis exists between macrophage apoE and LRP-1 to minimize inflammation and uncontrolled cell death by maintaining an optimal balance between macrophage survival and efferocytosis of apoptotic cells. To study the effects of macrophage LRP-1 on cellular apoptosis, we used a macrophage-specific LRP-1 Ϫ/Ϫ mouse we developed using a Cre/lox-based approach. 3, 31 Mice expressing floxed loxP sites flanking the LRP gene (provided by Dr. Joachim Hertz (University of Texas Southwestern Medical Center, Dallas, Tex) were crossed with mice expressing Cre recombinase, under the control of the macrophage specific chick lysozyme M promoter (provided by Dr. Irmgard Forester, Cologne, Germany), resulting in macrophage LRP1 (MLRP-1 Ϫ/Ϫ ) deficient mice. Through assessment of annexin V binding of membrane-exposed phosphatidylserine, TUNEL staining, and analyses of activated caspase 3, we show that deletion of LRP-1 increases cellular apoptosis with and without exogenous stimulation of cell death and in the absence or presence of cholesterol overload. The enhanced induction of apoptosis was associated with enhanced inflammation. Furthermore, our studies demonstrate that deletion of macrophage LRP-1 impairs efferocytosis of apoptotic cells and increases susceptibility to apoptosis by suppressing the pAkt pathway. All events occurred under conditions of enhanced apoE expression, thus suggesting that the antiinflammatory, prosurvival, and efferocytosis effects mediated by apoE depend on its interaction with LRP-1. More importantly, we show that macrophage LRP-1-deficient lesions have excessive accumulation of TUNEL-positive cells, more dead cells not associated with macrophages, and markedly increased necrotic core formation compared to lesions containing WT macrophages. Taken together, our studies demonstrate an atheroprotective role for the LRP-1/apoE axis in preventing necrotic core formation by regulating the balance between apoptosis susceptibility and efferocytosis.
Materials and Methods
A detailed description of all Materials and Methods is available in the Supplemental materials (available online at http://atvb.ahajournals.org).
In Vivo and In Vitro Analysis of Macrophage Apoptosis
For in vivo analysis, cells taken directly from the peritoneal cavity were subjected to flow cytometry analysis of AnnexinV/7aaD (BD Biosciences) and CD11b. For in vitro analysis, WT and LRP-1 Ϫ/Ϫ peritoneal macrophages were incubated for 24 hours in DMEM alone or containing either lipopolysaccharide (LPS; 50 ng/mL) or copperoxidized LDL (50 g protein/mL). Cell death was determined by TUNEL (Roche). Activated caspase 3 was performed using Nuc-View Caspase Detection kit (Biotium).
In Vitro Measurement of the Efferocytosis of Apoptotic Macrophages
WT, LRP-1 Ϫ/Ϫ , or apoE Ϫ/Ϫ peritoneal macrophages were labeled with carboxy-fluorescein diacetate succinimidyl ester (Molecular Probes) cell tracer and made apoptotic by incubation with either staurosporine (5 g/mL) for 24 hours or BAY11-7082 (20 mol/L) for 2 hours. Apoptotic cells were then incubated for 2 hours with fresh phagocyte. After vigorous washing with phosphate-buffered saline, the phagocytes were fixed in 4% paraformaldehyde, counterstained with DAPI, and efferocytosis of apoptotic cells was visualized using fluorescence microscopy.
Analysis of Efferocytosis in the Peritoneal Cavity
Carboxy-fluorescein diacetate succinimidyl ester cell tracer greenlabeled WT macrophages were made apoptotic by the addition of 20 mol/L Bay 11-7082 in serum-free DMEM for 2 hours. Then, 20ϫ10 6 cells in 1 mL of phosphate-buffered saline were injected into WT or M⌽LRP-1 Ϫ/Ϫ mice that had been injected 2 days previously with 1 mL of 3.0% thioglycollate. One hour later, the peritoneal cells were harvested and viable cells were labeled by incubation with nonfluorescent C 12 -resazurin, which metabolizes to red fluorescent C 12 -resorufin (Invitrogen). The macrophage phagocytes were then labeled using rat antimouse CD68-biotin antibody (Serotec) and streptavidin-Alexa Fluor 647 conjugate. Flow cytometry was then performed on 5-laser BD LSRII using FACSDiva 6.0 software (BD Biosciences). Cells positive for carboxy-fluorescein diacetate succinimidyl ester plus CD68 plus C 12 -resorufin vs CD68 plus C 12resorufin only were considered to be phagocytes positive for uptake of apoptotic cells.
Analysis of Atherosclerotic Lesion Apoptosis, Efferocytosis, and Necrosis
Recipient LDLR Ϫ/Ϫ mice (female, 6-weeks-old) were lethally irradiated and transplanted with bone marrow (BM) cells from female WT or M⌽LRP Ϫ/Ϫ mice. Four weeks later, the mice were placed on a western-type diet for 16 weeks. Apoptotic cells were detected in 5-M proximal aortic cryosections by TUNEL using the in situ cell death detection kit, TMR red (Roche). Nuclei were counterstained with Hoechst, and images of 5 serial sections from each mouse were taken using fluorescence microscopy. The efferocytosis in lesions after the procedure was as described by Schrijvers et al 32 and as modified by Thorp et al. 10 The same sections that were stained with TUNEL and Hoechst were stained for macrophages using a rabbit antimacrophage antibody (AIA31240; Accurate Chemical and Scientific), goat antirabbit biotinylated conjugated secondary antibody, and Alexa Fluor 488 (Molecular Probes). The free vs macrophageassociated apoptotic cells or bodies were then counted. Lesion necrosis was detected by staining with Harris hematoxylin and eosin (H&E) and quantitated by measuring the hematoxylin and eosinnegative acellular area in the intima vs total intimal area.
Macrophage Survival and Apoptotic Proteins
Total Akt, pAkt, and phosphorylated Bad were detected by Western blot using rabbit polyclonal antibodies to Akt, pAkt (serine 473) , and phosphorylated Bad (serine 136) (Cell Signaling Technology). Protein signal was detected using goat antirabbit IgG secondary antibody conjugated to horseradish peroxidase and the ECL plus chemiluminescence kit.
ApoE Secretion and Immunocytochemistry
Medium apoE was detected by Western blot using rabbit antiserum against mouse apoE and goat antirabbit horseradish peroxidaseconjugated IgG. Immunocytochemistry of cell apoE was performed using rabbit antiserum against mouse apoE and FITC-conjugated goat antirabbit IgG. Cells were counterstained using Vectashield with DAPI to visualize nuclei (Vector Labs).
Statistical Analysis
In vitro data are expressed as meanϮSD of triplicate determinations. In vivo data are expressed as meanϮSEM. Differences between 2 mean values were determined by 2-tailed Student t test, 1-way ANOVA (Bonferroni post test), and Mann-Whitney test. PϽ0.05 was considered to be significant.
Results

Effects of Macrophage LRP-1 Deletion on ApoE Synthesis and Secretion
Because apoE is a ligand for LRP-1 and may function in inflammatory signaling, regulation of efferocytosis, and apoptosis susceptibility, we first examined the effects of LRP-1 deletion on macrophage apoE synthesis and secretion. Western blot of 24-hour-conditioned media from unstimulated LRP-1 Ϫ/Ϫ macrophages (serum-free DMEM) showed a 3-fold increase in apoE accumulation compared to WT macrophages ( Figure 1A ). Because LRP-1 is an internalizing apoE receptor, the accumulation of apoE could simply represent inefficient local clearance. However, our findings that apoE mRNA levels increased by 5-fold in the absence of LRP-1 actually suggests the presence of a counter-regulatory loop ( Figure 1B ). Furthermore, immunohistochemical analyses showed that intracellular apoE was also increased in LRP-1 Ϫ/Ϫ macrophages after 24-hour incubation in DMEM alone ( Figure 1C , D).
Deletion of LRP-1 Increases Macrophage Death and Inflammation
To identify the influence of LRP-1 deletion on apoptosis susceptibility in vitro, WT or LRP-1 Ϫ/Ϫ macrophages were exposed to 3 apoptotic stimuli (nutrient deprivation with serum-free DMEM, inflammatory LPS, and cholesterol burden with oxidized LDL), and cell death was determined by TUNEL staining (Figure 2A, B ). After 24 hours of incubation in serum-free DMEM, the number of TUNEL-positive cells was 2.6-fold greater in cultures of LRP-1 Ϫ/Ϫ vs WT macrophages. In agreement with studies demonstrating that LPS enhances apoptosis of WT macrophages, 33, 34 stimulation for 24 hours with LPS vs DMEM alone resulted in increased numbers of TUNEL-positive cells in cultures of both WT and LRP-1 Ϫ/Ϫ cells. However, positivity for TUNEL staining was 1.8-fold more in LRP-1 Ϫ/Ϫ macrophages compared to WT cells (Figure 2A, B) . Similarly, incubation with oxidized LDL increased the TUNEL staining of both cell types, but the number of TUNEL-positive cells was 1.9-fold more in LRP-1 Ϫ/Ϫ macrophages. Under proapoptotic conditions, the inflammatory status of the LRP-1 Ϫ/Ϫ macrophages was heightened compared to WT cells. Incubation with serumfree DMEM resulted in 6.1-fold and 2.3-fold higher IL-1␤ and IL-6 mRNA levels in LRP-1 Ϫ/Ϫ macrophages compared to WT cells (Supplemental Figure I , available online at http://atvb.ahajournals.org). Whereas incubation with LPS increased the IL-1␤ and IL-6 mRNA levels in both cell types, this effect was enhanced in LRP-1 Ϫ/Ϫ macrophages (by 3-fold and 1.7-fold, respectively) compared to WT cells (Supplemental Figure I ). Similar to our previous results, 3 tumor necrosis factor (TNF)-␣, inducible nitric oxide synthase, and matrix metalloproteinase-9 mRNA levels were also increased in LRP-1 Ϫ/Ϫ macrophages with and without stimulation with LPS (data not shown). To investigate the relationship between activated apoptosis and inflammation in LRP-1 deficiency, we next examined the inflammatory response under conditions that induced similar numbers of apoptotic cells between the 2 cell types. To accomplish this goal, the cells were incubated with the nonspecific protein kinase inhibitor, staurosporine, which stimulates a high degree of apoptosis in macrophage cultures. 35 At a dose of 5 g/mL, staurosporine inhibits a broad range of cell survival kinases, including protein kinase C and protein kinase A, 36 and prevents the activation of Akt. 37 Staurosporine treatment led to similar levels of apoptotic macrophages in cultures of WT and LRP-1 Ϫ/Ϫ cells, as determined by annexin V binding ( Figure 2C ). Despite similar numbers of apoptotic cells under these conditions, LRP-1 Ϫ/Ϫ secreted 2-fold, 6-fold, and 3-fold more TNF-␣, IL-6, and IL-1␤, respectively, compared to WT macrophages ( Figure 2D ).
We next confirmed that LRP-1 deletion increased macrophage apoptosis in vivo. First, we performed flow cytometry to examine annexin V binding to membrane phosphatidylserine and 7aaD binding to exposed cellular DNA in macrophages (CD11b ϩ cells) from the peritoneal lavage cells of WT (nϭ3) and M⌽LRP-1 Ϫ/Ϫ (nϭ3) mice 4 days after stimulation with thioglycollate ( Figure 3A, B) . The deletion of macrophage LRP-1 induced a 2.3-fold increase in apoptosis (annexin V-positive cells; Figure 3A ) and a doubling of nonviable macrophages (annexin V-positive and 7aaDpositive cells; Figure 3B ). We also examined the effects of macrophage LRP-1 deletion on the accumulation of TUNELpositive cells in atherosclerotic lesions in WT and M⌽LRP-1 Ϫ/Ϫ BM recipient LDLR Ϫ/Ϫ mice fed a western diet for 16 weeks (Figure 3C, D) . The lesions of M⌽LRP-1 Ϫ/Ϫ (nϭ4) recipient LDLR Ϫ/Ϫ mice contained 7.3-fold more TUNELpositive cells compared to mice transplanted with WT (nϭ5) BM ( Figure 3C, D) . In the lesions of both WT and M⌽LRP-1 Ϫ/Ϫ recipient LDLR Ϫ/Ϫ mice, the TUNEL-positive cells were localized to macrophage-enriched areas ( Figure 3E ).
Macrophage LRP-1 Deletion Increases Susceptibility to Apoptosis by Impairing the pAkt Survival Pathway
A number of studies, including ours, have demonstrated that the pAkt pathway is fundamental in reducing WT macrophage susceptibility to apoptosis. 15, 17, 18 Because earlier studies demonstrated that antibody ligation to macrophage LRP-1 increases intracellular calcium mobilization, cAMP, and diacylglycerol, 13, 14 we next determined whether deletion of macrophage LRP-1 affects activation of Akt. Compared to WT macrophages, LRP-1 Ϫ/Ϫ cells had markedly decreased levels of pAkt (serine 473) when incubated with either serumfree DMEM alone or with LPS ( Figure 4A ). Similar differences were observed with pAkt (threonine 308) levels (data not shown). Interestingly, total Akt levels were also decreased in LRP-1 Ϫ/Ϫ macrophages vs WT cells in the presence of DMEM alone or with LPS ( Figure 4A ). This effect was likely attributable to decreased levels of Akt1 mRNA ( Figure 4B ). One mechanism by which pAkt prevents apoptosis is by phosphorylating Bad. 38 When Bad is phosphorylated, it loses its ability to complex with both Bcl-2 and Bcl-xL, thus allowing these 2 antiapoptotic proteins to prevent the activa- tion of caspase 9 and caspase 3. 38, 39 In keeping with the decreased pAkt, levels of phosphorylated Bad (serine 136) were decreased in LRP-1 Ϫ/Ϫ macrophages treated with either DMEM alone or LPS when compared to WT cells ( Figure  4A ). Consistent with the changes in pAkt and phosphorylated Bad (serine 136) , immunohistochemical analyses showed increased activated caspase 3 by LRP-1 Ϫ/Ϫ macrophages, even in the absence of exogenous cell death stimulation ( Figure  4C ). Thus, suppression of the pAkt survival pathway likely contributes to the increased numbers of apoptotic cells in cultures of LRP-1 Ϫ/Ϫ macrophages ( Figure 2 ) and in lesions of M⌽LRP-1 Ϫ/Ϫ recipient LDLR Ϫ/Ϫ mice ( Figure 3D ).
Effects of Macrophage LRP-1 Deletion on Efferocytosis of Apoptotic Cells
Because LRP-1 has been suggested to play a role in the uptake of apoptotic cells, we next determined whether deletion of macrophage LRP-1 reduced the uptake of apoptotic WT macrophages. To examine this possibility, carboxy-fluo-rescein diacetate succinimidyl ester-labeled WT cells were made apoptotic by incubation with staurosporine and then added to WT or LRP-1 Ϫ/Ϫ macrophages ( Figure 5A, B) . Eighty-three percent of the WT cells treated with staurosporine were apoptotic, as determined by annexin V binding. Deletion of macrophage LRP-1 decreased the uptake of WT apoptotic cells by 60% ( Figure 5C ), suggesting that the increased numbers of apoptotic/nonviable cells in LRP-1 Ϫ/Ϫ cultures (Figure 2 ) result in part from impaired efferocytosis. Because ABCA7 is linked to efficient phagocytosis of apoptotic bodies via LRP-1 signaling 8 and interacts with the amphipathic helical apoproteins, 40 we also determined the effects of LRP-1 deletion on ABCA7 synthesis. Deletion of macrophage LRP-1 resulted in a Ͼ4-fold increase in ABCA7 mRNA synthesis compared to WT cells ( Figure 5D ), suggesting that the lack of efferocytosis via LRP-1 results in compensatory upregulation of its partner, ABCA7.
Interestingly, the impaired efferocytosis occurs under conditions of a marked increase in apoE secretion by LRP-1 Ϫ/Ϫ macrophages ( Figure 1A) and despite a 9-fold increase in apoE synthesis in WT cells made apoptotic by treatment with 
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Plaque Cellularity and Macrophage LRP-1 staurosporine (data not shown). This suggests that apoE depends on LRP-1 for its effects on efferocytosis. To more directly examine a role for the LRP-1/apoE in efferocytosis, we compared the phagocytosis of WT, apoE Ϫ/Ϫ , and LRP-1 Ϫ/Ϫ apoptotic macrophages by WT, apoE Ϫ/Ϫ , and LRP-1 Ϫ/Ϫ efferocytes ( Figure 5E ). Compared to the uptake by WT phagocytes, phagocytosis of WT apoptotic cells by LRP-1 Ϫ/Ϫ phagocytes was decreased by 64%, and that by apoE Ϫ/Ϫ phagocytes was decreased by 70%. These data demonstrate that phagocytederived apoE facilitates phagocytosis and is consistent with studies suggesting that LRP-1 interaction with cell-surface apoE is enhanced via an endogenous secretion capture mechanism. 41 Compared to the phagocytosis of WT apoptotic cells, the uptake of apoE Ϫ/Ϫ apoptotic macrophages by WT phagocytes was decreased by 56%, demonstrating that apoptotic cell apoE is also important in efferocytosis. The uptake of apoE Ϫ/Ϫ apoptotic cells by LRP-1 Ϫ/Ϫ phagocytes was also decreased but was not significantly different compared to uptake of WT apoptotic cells. The complete absence of apoE caused the largest reduction in efferocytosis, which was significantly different compared to uptake of WT apoptotic cells by LRP-1 Ϫ/Ϫ , suggesting that other receptors besides LRP-1 contribute in small part to apoE-mediated efferocytosis. Consistent with a critical role for the LRP-1/apoE axis, the phagocytosis of LRP-1 Ϫ/Ϫ apoptotic macrophages, which express more apoE than WT cells, was significantly enhanced in WT and apoE Ϫ/Ϫ phagocytes but not in LRP-1 Ϫ/Ϫ efferocytes ( Figure 5E ).
Deletion of Macrophage LRP-1 Impairs Efferocytosis and Promotes Necrosis In Vivo
We examined the in vivo phagocytosis of WT apoptotic cells by peritoneal macrophages of both WT (nϭ4) and M⌽LRP-1 Ϫ/Ϫ (nϭ5) mice ( Figure 6A ). Compared to the efferocytosis of WT apoptotic macrophages by peritoneal phagocytes in WT mice, the phagocytosis in M⌽LRP-1 Ϫ/Ϫ mice was decreased by 53%. We next determined whether lesional phagocytosis is defective in M⌽LRP-1 Ϫ/Ϫ (nϭ4) vs WT (nϭ5) BM recipient LDLR Ϫ/Ϫ mice fed a western diet for 16 weeks by following established procedures by Schrijvers et al 32 as modified by Thorp et al. 10 The number of TUNELpositive cells that were associated with viable macrophages vs the free TUNEL-positive cells (Figure 6C, D) was quantitated ( Figure 6B ). As depicted in the images (Figure 6C, D) , apoptotic cells or bodies were counted as free when they were not associated with or found in close proximity to viable macrophages (detected as Alexa Fluor 488-stained macrophage cytoplasm surrounding a Hoechst-stained nucleus). Apoptotic cells or bodies that were associated with macrophage cytoplasmic debris but not in contact or close proximity with viable macrophages were counted as free. Compared to lesions in WT BM recipient LDLR Ϫ/Ϫ mice, the ratio of free to macrophage-associated TUNEL-positive cells was 6.8-fold greater in lesions of M⌽LRP-1 Ϫ/Ϫ recipient mice ( Figure 6B) . Consistent with the defective lesional efferocytosis, the percent necrotic area was 5.7-fold greater in lesions of M⌽LRP-1 Ϫ/Ϫ (nϭ4) vs WT (nϭ5) BM recipient LDLR Ϫ/Ϫ mice ( Figure 6E) .
Discussion
Our previous studies demonstrated that macrophage LRP-1 expression paradoxically slows the development of atherosclerosis even though it increases uptake of remnant lipoproteins. 3 The enhanced atherosclerotic lesion formation that occurs with macrophage LRP-1 deletion is associated with disruption of the elastic lamina, heightened inflammation, and increased macrophage cellularity. 3 An imbalance between the rate of apoptosis and efferocytosis of dying cells by macrophages accelerates atherosclerosis by promoting postapoptotic necrosis, inflammation, and plaque instability. 7 The present studies show that deletion of macrophage LRP-1 increases cell death in vitro by impairing efferocytosis and by increasing susceptibility to apoptosis via suppression of Akt activation. More importantly, a critical in vivo role for LRP-1 is demonstrated by the findings that deletion of macrophage LRP-1 promoted marked increases in lesional TUNELpositive cells, free apoptotic cells, and necrotic area. In addition to causing an imbalance between efferocytosis and apoptosis susceptibility, absence of LRP-1 induced inflammation and increased apoE secretion. The increased apoE secretion by LRP-1 Ϫ/Ϫ macrophages is apparently at odds with the finding of increased atherosclerosis that occurs with macrophage LRP-1 deficiency, because increased expression of macrophage apoE in the vessel wall consistently has been linked to reduced atherogenesis in the mouse. 19 -21 This suggests that some or most of the beneficial effects of apoE in the artery wall involve interaction with LRP-1. The current studies provide evidence that atheroprotective functions of the LRP-1/apoE axis include regulation of macrophage inflammation, apoptosis susceptibility, and efferocytosis.
Role of the LRP-1/ApoE Axis in Efferocytosis
The present studies demonstrate that deletion of macrophage LRP causes marked reductions in efferocytosis of apoptotic cells in cultures of macrophages ( Figure 5C ) and in vivo in the peritoneal cavity ( Figure 6A ) and atherosclerotic lesions ( Figure 6B ), suggesting that the impaired efferocytosis by LRP-1 Ϫ/Ϫ macrophages contributes to the increased inflammation ( Figure 2D, Supplemental Figure 1 ) 3 and apoptosis seen in culture (Figure 2A, B ) and in atherosclerotic lesions ( Figure 3C, D) . It is also likely that defective efferocytosis contributes to the enhanced plaque necrosis ( Figure 6E ) and progression seen in vivo in the setting of macrophage LRP-1 deficiency. 3 The observation of impaired efferocytosis by LRP-1 Ϫ/Ϫ macrophages is consistent with other studies demonstrating decreased uptake of apoptotic cells by LRP-1 Ϫ/Ϫ nonphagocytic cells (ie, fibroblasts). 9 However, other studies have suggested that macrophage Mertk receptor, and not LRP-1, is required to mediate the phagocytosis of WT macrophages made apoptotic by free cholesterol burden. 4 In this regard, our findings that macrophage LRP-1 deletion promotes lesional apoptotic cell accumulation and necrosis demonstrates a critical role for LRP-1 in the efferocytosis of macrophages made apoptotic by stimuli that normally occur in atherosclerotic lesions. Studies have shown that ABCA7 binds to amphipathic helical apoproteins (apoE and apolipoprotein AI). 40 In macrophages, ABCA7 translocates to the cell membrane and colocalizes with LRP-1 to optimize signaling via LRP-1 and the efferocytosis of apoptotic cells. 8 Our demonstration that LRP-1 Ϫ/Ϫ macrophages upregulate ABCA7 mRNA synthesis by Ͼ4-fold ( Figure 5D ) suggests that impaired phagocytosis attributable to loss of LRP-1 results in compensatory upregulation of its partner, ABCA7, and that the function of ABCA7 in efferocytosis is specific to LRP-1.
Studies suggest that apoE plays a role in mediating efficient efferocytosis of apoptotic cells. ApoE Ϫ/Ϫ mice show increased numbers of apoptotic cells in different tissues and increased levels of inflammatory cytokines. Also, efferocytosis of apoE Ϫ/Ϫ apoptotic cells is impaired. 24 Furthermore, apoE avidly binds phosphatidylserine, 42 and the synthesis of apoE is markedly enhanced in macrophages undergoing apoptosis. 25, 26 The present studies show that the LRP-1 Ϫ/Ϫ macrophages have markedly impaired efferocytosis despite increased apoE expression, strongly suggesting that apoE largely depends on interaction with LRP-1 for its role in efferocytosis. Although we cannot exclude the possibility that apoE interacts with other receptors on lesion phagocytes besides LRP-1, or the possibility that other ligands interact with LRP-1, we propose that the LRP-1/apoE axis is a main mechanism for regulation of efferocytosis and, therefore, plaque cell integrity, necrosis, and inflammation. Consistent with this possibility, the uptake of LRP-1 Ϫ/Ϫ apoptotic macrophages, which express more apoE than WT cells, was enhanced in both WT and apoE Ϫ/Ϫ macrophages, but not in LRP-1 Ϫ/Ϫ phagocytes ( Figure 5E ). It can also be postulated that the endogenous synthesis of apoE in the lesion, where plasma apoE has limited access, 43 provides a means for optimal cooperation with LRP-1 on neighboring phagocytes for efficient efferocytosis.
Role of the LRP-1/ApoE Axis in Akt Activation
Our studies demonstrate that deletion of macrophage LRP-1 suppresses activation of Akt, resulting in decreased phosphorylation of Bad and increased caspase 3 activation (Figure 4) . Thus, suppression of the pAkt pathway likely contributes to the increased cell death in LRP-1 Ϫ/Ϫ macrophage cultures and in LRP-1 Ϫ/Ϫ lesions, which is substantiated by studies showing that Akt activation is a critical determinant of macrophage survival. 15, 17, 18 The impairment in Akt activation is consistent with studies showing that macrophage LRP-1 signaling increases intracellular cAMP, diacylglycerol, and calcium mobilization, which are important second messengers leading to Akt phosphorylation. 15, 16 Furthermore, recent studies demonstrated that knockdown of LRP-1 in Schwann cells decreases pAkt levels. 44 Decreased synthesis of Akt1 mRNA contributed to the reduction in Akt activation in LRP-1 Ϫ/Ϫ macrophages (Figure 4 ), suggesting that the multiple downstream effects of LRP-1 signaling also regulate transcription of Akt1. A critical determinant of Akt1 transcription in macrophages is the transcription factor CREB, which is activated downstream from cAMP production. 45 It is of interest to note that consistent with LRP signaling stimulating cAMP production, recent studies demonstrated that antibodies to LRP increased the levels of phosphorylated CREB in neuronal cells. 46 Like LRP-1, apoE has been implicated in cell survival. ApoE stimulates activation of Akt in neuronal cells in a calcium-and cAMP-dependent manner. 28 In addition, apoE interaction with macrophages increases intracellular calcium mobilization and diacylglycerol production. Interestingly, this effect is inhibited by receptorassociated protein. 14 Thus, it is likely that interaction of endogenous apoE with macrophage LRP-1 promotes activation of Akt and reduces apoptosis susceptibility. Although a number of LDL receptor family members have been implicated in the survival effects of apoE on neuronal cells, 28 -30 our studies suggest that in macrophages, the prosurvival effects of apoE depend on interaction with LRP-1.
Role of the LRP-1/ApoE Axis in Macrophage Inflammation
Studies show that macrophage apoptosis attributable to either oxidative stress 47 or free cholesterol stimulation 48 is associated with increased inflammation. Our results show that heightened inflammation occurs in apoptotic LRP-1 Ϫ/Ϫ macrophages even without exogenous stimulation or cholesterol burden (Supplemental Figure 1A, B ). 3, 49 Furthermore, even when comparable numbers of apoptotic cells are induced in cultures of WT vs LRP-1 Ϫ/Ϫ macrophages by incubation with a nonspecific protein kinase inhibitor ( Figure 2C) , the LRP-1 Ϫ/Ϫ macrophages exhibit markedly increased secretion of inflammatory cytokines compared to WT cells ( Figure 2D ), thus demonstrating that regardless of either the degree or the mode of apoptosis, the deletion of LRP results in enhanced inflammation. This suggests that LRP-1 is a critical player in controlling macrophage inflammation. Besides impaired efferocytosis, other mechanisms may mediate the LRP-1 effects on inflammation. Addition of exogenous apoE 50, 51 or expression of endogenous apoE 52, 53 reduces inflammation in macrophages stimulated with LPS and interferon-␥. Furthermore, our previous studies demonstrated that deletion of macrophage LRP increases nuclear factor (NF)-␤ activation. 49 Interestingly, the antiinflammatory effects of apoE involve decreased NF-␤ activation during LPS stimulation of macrophages. 52 It is also likely that the LRP-1/apoE interaction regulates inflammation by impairing the TNF receptor-1 (TNFR-1) pathway, because we previously showed that deletion of LRP-1 results in increased cell surface TNFR-1, which binds TNF-␣ and causes enhanced NF-␤ activation and inflammation. 49 Because NF-␤ activation can also promote cell survival, 54 the enhanced NF-␤ activation that occurs with LRP-1 deficiency is somewhat at odds with the simultaneous increase in cell death. However, in some cell types, NF-␤ activation can promote either cell survival or apoptosis via selective gene regulation depending on the pathway of stimulation (ie, growth factor vs etoposide). 55, 56 Thus, it is plausible that NF-␤ activation via the TNF-␣/TNFR-1 pathway is proapoptotic and contributes to the enhanced cell death in LRP-1 Ϫ/Ϫ macrophages. Consistent with this possibility are studies demonstrating that TNF-␣ stimulates apoptosis via nitric oxide production. 6 In addition, we have obtained evidence that the expression of proapoptotic death receptor-5 and its ligand TRAIL 57,58 is increased, whereas that of antiapoptotic Bcl-xL is decreased in LRP-1 Ϫ/Ϫ macrophages (Yancey et al, unpublished observations).
In summary, our studies demonstrate that deletion of macrophage LRP-1 creates an imbalance between efferocytosis and apoptosis susceptibility resulting in enhanced inflammation, lesion cell death, and plaque necrosis. Because these effects were accompanied by increased apoE secretion in LRP-1 Ϫ/Ϫ macrophages, a functional axis between these 2 proteins may play a unique and dominant role in atherogenesis.
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